The clinical effects of inclisiran, a first-in-class LDL-C lowering siRNA therapy, on the LDL-C levels in Chinese patients with hypercholesterolemia
- Resource Type
- Article
- Source
- In
Journal of Clinical Lipidology May-June 2023 17(3):392-400 - Subject
- Language
- ISSN
- 1933-2874